Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinasesOscar Saavedra, Stephen Claridge, Lijie Zhan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemiaRebecca B Klisovic, Wendy Stock, Spero Cataland, et al.Cancer Research|March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1-HK2+ Multiple MyelomaShili Xu, Tianyuan Zhou, Hanna M Doh, et al.Science Translational Medicine|June 16, 2017
Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRASSarah J Ross, Alexey S Revenko, Lyndsey L Hanson, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitorsArkadii Vaisburg, Naomy Bernstein, Sylvie Frechette, et al.Journal of Experimental & Clinical Cancer Research : CR|March 5, 2024
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapyYun Hu, Alexey Revenko, Hampartsoum Barsoumian, et al.Cell Reports|April 13, 2016
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate CancerYu Zhao, Liguo Wang, Shancheng Ren, et al.The New England Journal of Medicine|March 16, 2022
Inhibition of Prekallikrein for Hereditary AngioedemaLauré M Fijen, Marc A Riedl, Laura Bordone, et al.Journal of Hepatology|December 18, 2020
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetMassih Ningarhari, Stefano Caruso, Théo Z Hirsch, et al.Bioorganic & Medicinal Chemistry Letters|May 23, 2006
Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: novel classes of histone deacetylase inhibitorsOscar Moradei, Silvana Leit, Nancy Zhou, et al.Pageof 9